Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News

  News Archive

bluebird bio, Medigene Establish Strategic Alliance
Friday, September 30, 2016
T cell receptor (TCR) therapeutic candidates against four targets to be generated using Medigene’s proprietary TCR technology platform and bluebird bio’s lentiviral vector, genome editing, synthetic biology, and manufacturing capabilities.

Faecal Bacteria Linked to Body Fat
Friday, September 30, 2016
Researchers at King’s College London have found a new link between the diversity of bacteria in human poo – known as the human faecal microbiome - and levels of abdominal body fat.

Anti-Inflammatory Drugs Could Strengthen Airway Immunity
Thursday, September 29, 2016
Mold toxins can weaken the airways' clearing mechanisms and immunity, but PKC inhibitors showed promise as a treatment.

Boehringer Ingelheim Collaboration with Viratherapeutics
Thursday, September 29, 2016
Boehringer Ingelheim, Viratherapeutics collaborate to develop next-gen oncolytic virus platform.

Antibodies Paving the Way to HIV Vaccine
Wednesday, September 28, 2016
Researchers uncover factors responsible for the formation of broadly neutralizing HIV antibodies in humans.

Vaccine Against Common Cold Achievable
Wednesday, September 28, 2016
Researchers suggest that a vaccine against rhinoviruses is possible using variant virus vaccines.

Immunic Acquires 4SC’S Immunology Portfolio
Wednesday, September 28, 2016
Company has acquired two promising drug development programs with validated targets known to be relevant in various immune and autoimmune diseases.

Point of Care Diagnostics - A Cautious Revolution
Wednesday, September 28, 2016
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.

MD Anderson Cancer Center, Adaptimmune Form Strategic Alliance
Tuesday, September 27, 2016
Alliance to expedite development of novel adoptive T-cell therapies for multiple types of cancer.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 2040
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!